Background: Therapeutic hypothermia (TH) is an established treatment after cardiac arrest and growing evidence supports its use as neuroprotective treatment in stroke. Only few and heterogeneous studies exist on the effect of hypothermia in subarachnoid hemorrhage (SAH). A novel approach of early and prolonged TH and its influence on key complications in poor-grade SAH, vasospasm and delayed cerebral ischemia (DCI) was evaluated. Methods: This observational matched controlled study included 36 poor-grade (Hunt and Hess Scale >3 and World Federation of Neurosurgical Societies Scale >3) SAH patients. Twelve patients received early TH (<48 h after ictus), mild (35°C), prolonged (7 ± 1 days) and were matched to 24 patients from the prospective SAH database. Vasospasm was diagnosed by angiography, macrovascular spasm serially evaluated by Doppler sonography and DCI was defined as new infarction on follow-up CT. Functional outcome was assessed at 6 months by modified Rankin Scale (mRS) and categorized as favorable (mRS score 0-2) versus unfavorable (mRS score 3-6) outcome. Results: Angiographic vasospasm was present in 71.0% of patients. TH neither influenced occurrence nor duration, but the degree of macrovascular spasm as well as peak spastic velocities were significantly reduced (p < 0.05). Frequency of DCI was 87.5% in non-TH vs. 50% in TH-treated patients, translating into a relative risk reduction of 43% and preventive risk ratio of 0.33 (95% CI 0.14-0.77, p = 0.036). Favorable functional outcome was twice as frequent in TH-treated patients 66.7 vs. 33.3% of non-TH (p = 0.06). Conclusion: Early and prolonged TH was associated with a reduced degree of macrovascular spasm and significantly decreased occurrence of DCI, possibly ameliorating functional outcome. TH may represent a promising neuroprotective therapy possibly targeting multiple pathways of DCI development, notably macrovascular spasm, which strongly warrants further evaluation of its clinical impact.

Keywords:
Hypothermia, Subarachnoid hemorrhage, Vasospasm, Delayed cerebral infarction
1.
Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G: European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013;35:93-112.
2.
Macdonald RL: Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 2014;10:44-58.
3.
Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD: Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol 2013;9:152-163.
4.
Woitzik J, Dreier JP, Hecht N, Fiss I, Sandow N, Major S, Winkler M, Dahlem YA, Manville J, Diepers M, Muench E, Kasuya H, Schmiedek P, Vajkoczy P: Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2012;32:203-212.
5.
Leng LZ, Fink ME, Iadecola C: Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Arch Neurol 2011;68:31-36.
6.
Linares G, Mayer SA: Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit Care Med 2009;37(7 suppl):S243-S249.
7.
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-556.
8.
Nielsen N, Wetterslev J, Friberg H: Targeted temperature management after cardiac arrest. N Engl J Med 2014;370:1360.
9.
van der Worp HB, Macleod MR, Kollmar R: Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab 2010;30:1079-1093.
10.
Kollmar R, Staykov D, Dörfler A, Schellinger PD, Schwab S, Bardutzky J: Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke 2010;41:1684-1689.
11.
Kollmar R, Gebhardt B, Schwab S: [EuroHYP-1 trial: EU-funded therapy study on the effectiveness of mild therapeutic hypothermia for acute ischemic stroke]. Nervenarzt 2012;83:1252-1259.
12.
Török E, Klopotowski M, Trabold R, Thal SC, Plesnila N, Schöller K: Mild hypothermia (33 degrees C) reduces intracranial hypertension and improves functional outcome after subarachnoid hemorrhage in rats. Neurosurgery 2009;65:352-359; discussion 359.
13.
Todd MM, Hindman BJ, Clarke WR, Torner JC: Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005;352:135-145.
14.
Seule MA, Muroi C, Mink S, Yonekawa Y, Keller E: Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery 2009;64:86-92; discussion 92-93.
15.
Badjatia N, Strongilis E, Gordon E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Ostapkovich ND, Mayer SA: Metabolic impact of shivering during therapeutic temperature modulation: the bedside shivering assessment acale. Stroke 2008;39:3242-3247.
16.
Geurts M, Macleod MR, Kollmar R, Kremer PH, van der Worp HB: Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med 2013;42:231-242.
17.
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2012;43:1711-1737.
18.
Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J: Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med 2011;39:1766-1772.
19.
Voicu S, Deye N, Malissin I, Vigué B, Brun PY, Haik W, Champion S, Megarbane B, Sideris G, Mebazaa A, Carli P, Manivet P, Baud FJ: Influence of α-stat and pH-stat blood gas management strategies on cerebral blood flow and oxygenation in patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest: a crossover study. Crit Care Med 2014;42:1849-1861.
20.
Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA: Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006;59:21-27; discussion 21-27.
21.
Hijdra A, Brouwers PJ, Vermeulen M, van Gijn J: Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke 1990;21:1156-1161.
22.
Kiphuth IC, Huttner HB, Breuer L, Engelhorn T, Schwab S, Köhrmann M: Vasospasm in intracerebral hemorrhage with ventricular involvement: a prospective pilot transcranial Doppler sonography study. Cerebrovasc Dis 2011;32:420-425.
23.
Lysakowski C, Walder B, Costanza MC, Tramèr MR: Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 2001;32:2292-2298.
24.
Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P: Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989;100:12-24.
25.
de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ: Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 2013;44:43-54.
26.
Vergouwen MD, Algra A, Rinkel GJ: Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2012;43:2671-2676.
27.
Wong GK, Poon WS: Clazosentan for patients with subarachnoid haemorrhage: lessons learned. Lancet Neurol 2011;10:871; author reply 871-872.
28.
Wang ZP, Chen HS, Wang FX: Influence of plasma and cerebrospinal fluid levels of endothelin-1 and NO in reducing cerebral vasospasm after subarachnoid hemorrhage during treatment with mild hypothermia, in a dog model. Cell Biochem Biophys 2011;61:137-143.
29.
Muroi C, Frei K, El Beltagy M, Cesnulis E, Yonekawa Y, Keller E: Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2008;20:193-198.
30.
Muroi C, Hugelshofer M, Seule M, Tastan I, Fujioka M, Mishima K, Keller E: Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2013;72:367-375; discussion 375.
31.
Seule M, Muroi C, Sikorski C, Hugelshofer M, Winkler K, Keller E: Therapeutic hypothermia reduces middle cerebral artery flow velocity in patients with severe aneurysmal subarachnoid hemorrhage. Neurocrit Care 2014;20:255-262.
32.
Takaoka S, Pearlstein RD, Warner DS: Hypothermia reduces the propensity of cortical tissue to propagate direct current depolarizations in the rat. Neurosci Lett 1996;218:25-28.
33.
Kaneko T, Kibayashi K: Mild hypothermia facilitates the expression of cold-inducible RNA-binding protein and heat shock protein 70.1 in mouse brain. Brain Res 2012;1466:128-136.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.